Company profile: Keystone Heart
1.1 - Company Overview
Company description
- Provider of embolic cerebral protection medical devices for cardiovascular and structural heart procedures, developing and manufacturing devices that protect the brain from emboli and reduce the risk of brain infarcts during TAVR, AF ablation, and other procedures.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Keystone Heart
Neuraxpharm
HQ: Germany
Website
- Description: Provider of branded and generic CNS pharmaceuticals and nutraceuticals in main European countries, developing and commercializing products for CNS disorder prevention and treatment. Develops and manufactures finished dosage forms (mainly solid oral) for CNS and other areas; includes Buccolam for acute pediatric seizures and Preventan for immune support. Also offers LepsiApp for epilepsy management, R&D (actives, bioequivalence, regulatory), and pharmacovigilance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neuraxpharm company profile →
CanniMed
HQ: Canada
Website
- Description: Provider of standardized, pharmaceutical-grade medical cannabis in Canada, operating as a plant biopharmaceutical company under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CanniMed company profile →
Q'Apel Medical
HQ: United States
Website
- Description: Provider of neurovascular access and stroke intervention devices, including the Walrus Balloon Catheter System for mechanical thrombectomy with a large inner diameter and high trackability; the Hippo Advanced Aspiration System for rapid clot removal with visible clot engagement and flexible navigation; and the Armadillo Neurovascular Access System with dual-mode radial and femoral adaptability, trackability, and support for complex anatomy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q'Apel Medical company profile →
Neuron Bio
HQ: Spain
Website
- Description: Provider of innovative biosolutions: AlzTEST blood biomarker diagnostic for Alzheimer’s; Omega-3 DHA microalgae oil for functional foods and nutraceuticals; MicroBiOil platform for microbial oils and oleochemicals; Microbiotools by Neol for bioprocess development; custom R&D in biomedicine, toxicology and agro-food; and a drug discovery platform for neurodegenerative diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neuron Bio company profile →
ADRx
HQ: United States
Website
- Description: Provider of a structure-based drug discovery platform that transforms atomic structures into small molecule therapies for protein aggregation diseases, targeting pathological protein structures. Develops small molecule modulators of protein-protein interactions, including amyloids and biomolecular condensates, and advances drug candidates for Alzheimer’s, systemic amyloidosis, ovarian cancer, ALS, and Parkinson’s.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ADRx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Keystone Heart
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Keystone Heart
2.2 - Growth funds investing in similar companies to Keystone Heart
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Keystone Heart
4.2 - Public trading comparable groups for Keystone Heart
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →